Insuline Medical Total Asset vs. Current Asset

INSL Stock  ILS 222.00  5.20  2.29%   
Taking into consideration Insuline Medical's profitability measurements, Insuline Medical may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Insuline Medical's ability to earn profits and add value for shareholders.
For Insuline Medical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Insuline Medical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Insuline Medical utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Insuline Medical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Insuline Medical over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Insuline Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insuline Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insuline Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Insuline Medical Current Asset vs. Total Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Insuline Medical's current stock value. Our valuation model uses many indicators to compare Insuline Medical value to that of its competitors to determine the firm's financial worth.
Insuline Medical is rated second overall in total asset category among its peers. It also is rated second overall in current asset category among its peers fabricating about  5.06  of Current Asset per Total Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value Insuline Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Insuline Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Insuline Current Asset vs. Total Asset

Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Insuline Medical

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
1.58 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

Insuline Medical

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

 = 
M
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.

Insuline Current Asset Comparison

Insuline Medical is currently regarded as number one stock in current asset category among its peers.

Insuline Medical Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Insuline Medical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Insuline Medical will eventually generate negative long term returns. The profitability progress is the general direction of Insuline Medical's change in net profit over the period of time. It can combine multiple indicators of Insuline Medical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel. Insuline Medical is traded on Tel Aviv Stock Exchange in Israel.

Insuline Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Insuline Medical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Insuline Medical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Insuline Medical's important profitability drivers and their relationship over time.

Use Insuline Medical in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Insuline Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Insuline Medical will appreciate offsetting losses from the drop in the long position's value.

Insuline Medical Pair Trading

Insuline Medical Pair Trading Analysis

The ability to find closely correlated positions to Insuline Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Insuline Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Insuline Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Insuline Medical to buy it.
The correlation of Insuline Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Insuline Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Insuline Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Insuline Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Insuline Medical position

In addition to having Insuline Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Shipping Containers Thematic Idea Now

Shipping Containers
Shipping Containers Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Shipping Containers theme has 16 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Shipping Containers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Insuline Stock

To fully project Insuline Medical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Insuline Medical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Insuline Medical's income statement, its balance sheet, and the statement of cash flows.
Potential Insuline Medical investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Insuline Medical investors may work on each financial statement separately, they are all related. The changes in Insuline Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Insuline Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.